Medifast, Inc. (MED) Market Cap & Valuation Ratios
Medifast, Inc. (MED) has a market cap of $132.7M and a price-to-sales ratio of 0.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MEDMedifast, Inc.Follow MED — free
—
Price chart with a free account
- Market cap
- 132.7M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Peers
personal services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MED | 0.1 | — | — | — | 3.0% | -34% | -6% | -16% |
| ROL | 17 | 31.9 | 4.3 | 20.0 | 4.0% | +8% | 18% | 29% |
| SCI | 11 | 21.8 | 3.8 | 13.5 | 5.6% | +3% | 22% | 11% |
| HRB | 6.1 | 8.7 | 1.7 | 6.3 | 12.3% | +5% | 24% | 129% |
| FTDR | 5.8 | 22.3 | 3.0 | 12.1 | 6.6% | +9% | 20% | 39% |
| BFAM | 3.5 | 22.5 | 1.5 | 11.3 | 6.8% | +9% | 10% | 10% |
| CSV | 0.6 | 13.1 | 2.7 | 9.5 | 6.4% | +2% | 22% | 9% |
| Median of these 6 | 22.0 | 2.8 | 11.7 | 6.5% | +7% | 21% | 20% |
.
Growth vs. price
each dot a company · hover or tap for valuesMED has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
Medifast, Inc. — questions
- What is Medifast, Inc.'s market cap?
- $132.7M.
- What is Medifast, Inc.'s price-to-sales ratio?
- 0.4.
Every figure on this page comes from Medifast, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.